Evaluation of Evening Versus Morning Levothyroxine Intake in Elderly
NCT03614988 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208
Last updated 2019-10-14
Summary
A study designed to compare evening versus morning levothyroxine intake in the elderly.
Conditions
- Aging
- Primary Hypothyroidism
- Interaction Drug Food
Interventions
- OTHER
-
Evening Levothyroxine Administration
Bedtime levothyroxine intake, with 60-minute meal-free interval
- OTHER
-
Morning Levothyroxine Administration
Morning levothyroxine intake, 60 minutes before breakfast.
Sponsors & Collaborators
-
Federal University of Rio Grande do Sul
collaborator OTHER -
Hospital de Clinicas de Porto Alegre
lead OTHER
Principal Investigators
-
Renato Gorga Bandeira de Mello · Professor of the Post Graduate Program in Endocrinology at the Hospital de Clinicas de Porto Alegre
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-05-01
- Primary Completion
- 2019-11-30
- Completion
- 2020-03-31
Countries
- Brazil
Study Locations
More Related Trials
-
Mechanistic Study of Subclinical Hypothyroidism In the Elderly
NCT02399475 ·Status: COMPLETED ·Phase: NA
-
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
NCT01039818 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
NCT01831869 ·Status: UNKNOWN ·Phase: PHASE4
-
Hypothyroidism, Metabolism and Food Intake
NCT02993562 ·Status: COMPLETED
-
The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients With Subclinical Hypothyroidism
NCT00498238 ·Status: COMPLETED ·Phase: NA
-
Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism
NCT02186405 ·Status: WITHDRAWN ·Phase: PHASE4
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
NCT03096613 ·Status: UNKNOWN ·Phase: PHASE4
-
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
NCT00565864 ·Status: COMPLETED ·Phase: PHASE4
-
Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition
NCT02891668 ·Status: COMPLETED
-
Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients
NCT07133295 ·Status: COMPLETED
-
Timing of Thyroxine Dose In Ramadan
NCT05421468 ·Status: UNKNOWN ·Phase: NA
-
Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.
NCT03898622 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of L-carnitine on Hypothyroidism
NCT01769157 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
NCT01295333 ·Status: COMPLETED ·Phase: PHASE3
-
Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP
NCT01486667 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism
NCT02500342 ·Status: COMPLETED ·Phase: PHASE4
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism
NCT06135948 ·Status: COMPLETED ·Phase: PHASE4
-
LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.
NCT05682482 ·Status: RECRUITING ·Phase: PHASE3
-
Thyroxine Titration Study
NCT00111735 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism
NCT02316743 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism
NCT02090907 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism
NCT05371262 ·Status: COMPLETED ·Phase: PHASE4
-
Generic vs. Name-Brand Levothyroxine
NCT00403390 ·Status: COMPLETED ·Phase: NA
-
Recurrent Pregnancy Loss and Thyroid Disease
NCT03106935 ·Status: UNKNOWN ·Phase: EARLY_PHASE1